Work

Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time?

Year: 2009

Type: article

Abstract: Commentary to:A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growthJuho Suojanen, Tuula Salo, Erkki Koivunen, Timo Sorsa and Emma Pirilä

Source: Cancer Biology & Therapy

DOI: 10.4161/cbt.8.24.10353

Authors: Stanley Zucker, Jian Cao

Institution: Northport VA Medical Center

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $2,970

Funder: National Cancer Institute

Award: G1872011237

OpenAlex ID: W2053687002

FWCI: 2.1

Cites: 20

Cited by: 83

Related to: 10